79 related articles for article (PubMed ID: 19718517)
21. Specific capture of uranyl protein targets by metal affinity chromatography.
Basset C; Dedieu A; Guérin P; Quéméneur E; Meyer D; Vidaud C
J Chromatogr A; 2008 Mar; 1185(2):233-40. PubMed ID: 18308325
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins.
Shiyama T; Furuya M; Yamazaki A; Terada T; Tanaka A
Bioorg Med Chem; 2004 Jun; 12(11):2831-41. PubMed ID: 15142543
[TBL] [Abstract][Full Text] [Related]
23. Affinity capture of a mammalian DNA polymerase beta by inhibitors immobilized to resins used in solid-phase organic synthesis.
Kuramochi K; Haruyama T; Takeuchi R; Sunoki T; Watanabe M; Oshige M; Kobayashi S; Sakaguchi K; Sugawara F
Bioconjug Chem; 2005; 16(1):97-104. PubMed ID: 15656580
[TBL] [Abstract][Full Text] [Related]
24. Detection of the FK506-FKBP-calcineurin complex by a simple binding assay.
Asami M; Kuno T; Mukai H; Tanaka C
Biochem Biophys Res Commun; 1993 May; 192(3):1388-94. PubMed ID: 7685169
[TBL] [Abstract][Full Text] [Related]
25. Identification of small molecule binding molecules by affinity purification using a specific ligand immobilized on PEGA resin.
Kuramochi K; Miyano Y; Enomoto Y; Takeuchi R; Ishi K; Takakusagi Y; Saitoh T; Fukudome K; Manita D; Takeda Y; Kobayashi S; Sakaguchi K; Sugawara F
Bioconjug Chem; 2008 Dec; 19(12):2417-26. PubMed ID: 19035789
[TBL] [Abstract][Full Text] [Related]
26. FKBP family proteins: immunophilins with versatile biological functions.
Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of affinity ligands and relation of their structure with adsorption of proteins.
Ye L; Xu A; Cheng C; Zhang L; Huo C; Huang F; Xu H; Li R
J Sep Sci; 2011 Nov; 34(22):3145-50. PubMed ID: 22015803
[TBL] [Abstract][Full Text] [Related]
28. Immobilized analogues of sunflower trypsin inhibitor-1 constitute a versatile group of affinity sorbents for selective isolation of serine proteases.
Pereira HJ; Salgado MC; Oliveira EB
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):2039-44. PubMed ID: 19515617
[TBL] [Abstract][Full Text] [Related]
29. Properties of flaky affinity resin with co-continuous structure.
Mori T; Tanaka A; Kubo T; Kaya K; Sakamoto M; Hosoya K
Bioorg Med Chem; 2008 Feb; 16(4):1983-91. PubMed ID: 18037297
[TBL] [Abstract][Full Text] [Related]
30. Fluorescent probes to characterise FK506-binding proteins.
Kozany C; März A; Kress C; Hausch F
Chembiochem; 2009 May; 10(8):1402-10. PubMed ID: 19418507
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506.
Kotaka M; Ye H; Alag R; Hu G; Bozdech Z; Preiser PR; Yoon HS; Lescar J
Biochemistry; 2008 Jun; 47(22):5951-61. PubMed ID: 18465874
[TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
33. High brain densities of the immunophilin FKBP colocalized with calcineurin.
Steiner JP; Dawson TM; Fotuhi M; Glatt CE; Snowman AM; Cohen N; Snyder SH
Nature; 1992 Aug; 358(6387):584-7. PubMed ID: 1380130
[TBL] [Abstract][Full Text] [Related]
34. An immuno-chemo-proteomics method for drug target deconvolution.
Saxena C; Zhen E; Higgs RE; Hale JE
J Proteome Res; 2008 Aug; 7(8):3490-7. PubMed ID: 18590316
[TBL] [Abstract][Full Text] [Related]
35. Tools and methodologies capable of isolating and identifying a target molecule for a bioactive compound.
Sakamoto S; Hatakeyama M; Ito T; Handa H
Bioorg Med Chem; 2012 Mar; 20(6):1990-2001. PubMed ID: 22264760
[TBL] [Abstract][Full Text] [Related]
36. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
Gierse JK; Zhang Y; Hood WF; Walker MC; Trigg JS; Maziasz TJ; Koboldt CM; Muhammad JL; Zweifel BS; Masferrer JL; Isakson PC; Seibert K
J Pharmacol Exp Ther; 2005 Mar; 312(3):1206-12. PubMed ID: 15494548
[TBL] [Abstract][Full Text] [Related]
37. Isolation of an mRNA-binding protein involved in C-to-U editing.
Gerber CA; Relich A; Driscoll DM
Methods Mol Biol; 2004; 265():239-49. PubMed ID: 15103077
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and characterization of a new boronate affinity monolithic capillary for specific capture of cis-diol-containing compounds.
Ren L; Liu Z; Dong M; Ye M; Zou H
J Chromatogr A; 2009 Jun; 1216(23):4768-74. PubMed ID: 19419728
[TBL] [Abstract][Full Text] [Related]
39. Determination of the differential effects of hydrogen bonding and water release on the binding of FK506 to native and Tyr82-->Phe82 FKBP-12 proteins using free energy simulations.
Pearlman DA; Connelly PR
J Mol Biol; 1995 May; 248(3):696-717. PubMed ID: 7538591
[TBL] [Abstract][Full Text] [Related]
40. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G
J Med Chem; 2004 Jan; 47(3):550-7. PubMed ID: 14736236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
